Importantly, no bleeding complications were seen upon GPIb or GPVI blockade [37, 42, 60] in contrast to the futile treatment with anti-GPIIb/IIIa Fab fragments or humanized antibodies leading to severe intracranial hemorrhages (ICH) both in experimental [37] and clinical [2] stroke. The gene discussed is GP6; the disease is stroke disorder.